NEUROLOGICAL SOFT SIGNS AND SOCIAL COGNITION IN PATIENTS WITH SCHIZOPHRENIA: THE MISSING LINK

被引:0
|
作者
Guevara, Kaloyan [1 ,2 ]
Kostadinov, Kostadin [3 ]
机构
[1] Stavanger Univ Hosp, Dept Psychiat, 12 Jan Johnsens Gate, N-4011 Stavanger, Norway
[2] Med Univ Sofia, Dept Psychiat, 1St Georgi Sofiiski St, B-1431 Sofia, Bulgaria
[3] Medical Univ Plovdiv, Fac Publ Hlth, Dept Social Med & Publ Hlth, 15A Vasil Aprilov Blvd, Plovdiv 4002, Bulgaria
来源
关键词
schizophrenia; social cognition; neurological soft signs; NES; AKDEF; ABNORMALITIES;
D O I
10.7546/CRABS.2023.09.15
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Schizophrenia is a debilitating mental disorder characterised by a pro-nounced decline in mental, physical, and social functioning. Our study aims to investigate the relationship between the socio-cognitive and the subtle motor and sensory symptoms of schizophrenia, which are, respectively, represented by facial emotion recognition deficits (FERD) and neurological soft signs (NSS). Thus, we assessed 60 patients diagnosed with schizophrenia. FERD was mea-sured with the "Averaged Karolinska Directed Emotional Faces" set, and NSS was assessed with the Neurological Evaluation Scale. A strong and significant negative correlation was found between the NSS total score and the FERD total score (r = -0.7, p < 0.001). There was also a significant negative corre-lation between several of the subscores of both instruments. The results show that impaired social cognition is significantly associated with soft neurologi-cal disturbances in patients suffering from schizophrenia. Taken together, this reinforces the notion that schizophrenia is characterised by dysfunction and disconnection of a complex cerebral network, which can probably be influenced by psychosocial and physical nonpharmacological therapeutic interventions.
引用
收藏
页码:1440 / 1448
页数:9
相关论文
共 50 条
  • [41] Neurological soft signs in social phobia
    Hollander, E
    Weiller, F
    Cohen, L
    Kwon, JH
    Decaria, CM
    Liebowitz, MR
    Stein, DJ
    NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY, 1996, 9 (03): : 182 - 185
  • [42] Correlations between obstetric complications and neurological soft signs in Tunisian patients with schizophrenia
    Mrad, Amel
    Mechri, Anwar
    Slama, Hela
    Mokni, Sana
    Letaief, Mondher
    Gha, Lotfi
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2010, 64 (06) : 645 - 648
  • [43] Neurological soft signs in first-episode schizophrenia
    Shero, A
    Sanders, R
    McLaughlin, N
    Seeney, J
    Haas, G
    Keshavan, MS
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 31 - 31
  • [44] Soft neurological signs and sustained attention impairment in schizophrenia
    Chen, EYH
    Lam, LCW
    Wilkins, A
    SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 180 - 181
  • [45] Neurological soft signs (NSS) and neuropsychological deficits in schizophrenia
    Karr, M
    Schroder, J
    Tittel, A
    NERVENHEILKUNDE, 1996, 15 (06) : 326 - 331
  • [46] Neurological soft signs might be endophenotype candidates for patients with deficit syndrome schizophrenia
    Albayrak, Yakup
    Akyol, Esra Soydas
    Beyazyuz, Murat
    Baykal, Saliha
    Kuloglu, Murat
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 2825 - 2831
  • [47] Neurological soft signs significantly differentiate schizophrenia patients from healthy controls
    Fountoulakis, Konstantinos N.
    Panagiotidis, Panagiotis
    Gonda, Xenia
    Kimiskidis, Vasilios
    Nimatoudis, Ioannis
    ACTA NEUROPSYCHIATRICA, 2018, 30 (02): : 97 - 105
  • [48] 12-Month stability of neurological soft signs in stabilized patients with schizophrenia
    Fountoulakis, Konstantinos N.
    Panagiotidis, Panagiotis
    Kimiskidis, Vasilios
    Nimatoudis, Ioannis
    NORDIC JOURNAL OF PSYCHIATRY, 2019, 73 (07) : 451 - 461
  • [49] Neurological soft signs and response to risperidone in chronic schizophrenia
    Smith, RC
    Kadewari, RP
    BIOLOGICAL PSYCHIATRY, 1996, 40 (10) : 1056 - 1059
  • [50] Neurological soft signs in first-episode schizophrenia
    Ceskova, E
    Prikryl, R
    Kasparek, T
    Tronerova, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S313 - S313